Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
9(10)-Nitrooleate is a mixture of the nitroalkene endogenous lipid signaling molecules 9-nitrooleate (Item No. 10008042) and 10-nitrooleate (Item No. 10008043). 9(10)-Nitrooleate is formed by nitration of oleic acid (Item Nos. 90260 | 24659) by peroxynitrite, acidified nitrite, and myeloperoxidase (MPO) in the presence of hydrogen peroxide (H2O2) and nitrite.1 It induces transactivation of peroxisome proliferator-activated receptor γ (PPARγ) or nuclear factor erythroid 2-related factor 2 (Nrf2) in reporter assays using MCF-7 cells at ≥0.3 and ≥3 µM, respectively, and induces transactivation of PPARγ, PPARδ, or PPARα in reporter assays using CV-1 cells at 1 µM.1,2 It induces adipogenesis in 3T3-L1 preadipocytes and glucose uptake in differentiated 3T3-L1 adipocytes at 3 µM. In vivo, 9(10)-nitrooleate (500 µg/kg) decreases plasma TNF-α levels and kidney Mpo and IL-1β levels and reduces tubular necrosis and tubule dilation in a mouse model of renal ischemia-reperfusion injury.3 Lipid nanoparticles (LNPs) encapsulating 9(10)-nitrooleate and plasmid DNA (pDNA) do not activate STING in RAW 264.7 macrophages and are associated with lower plasma IFN-β and IL-6 levels and no mortality in mice as compared with pDNA-encapsulating LNPs without 9(10)-nitrooleate.4
WARNING This product is not for human or veterinary use.
1. Fatty acid transduction of nitric oxide signaling. Multiple nitrated unsaturated acid derivatives exist in human blood and urine serve as endogenous peroxisome proliferator-
2. Nitroalkene fatty acids mediate activation of Nrf2/ARE-
3. Nitro-
4. Safer non-